Potassium Chloride Tablet, Extended Release
FDA Label NDC 0904-7293

19 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Potassium Chloride (NDC 0904-7293). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, indications and usage, contraindications, warnings, general, information for patients, laboratory tests, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-7292-61

Unit Dose

Potassium Chloride

Extended-Release

Tablets, USP

10 mEq K

100 TABLETS (10 x 10)

Rx only

10meq K Carton Label (Fce0bed3 7798 466b 915b 4b6de9c366bb 01)

10meq K Carton Label (Fce0bed3 7798 466b 915b 4b6de9c366bb 01)

MAJOR®

NDC 0904-7293-61

Unit Dose

Potassium Chloride

Extended-Release

Tablets, USP

20 mEq K

100 TABLETS (10 x 10)

Rx only

20meq K Carton Label (Fce0bed3 7798 466b 915b 4b6de9c366bb 00)

20meq K Carton Label (Fce0bed3 7798 466b 915b 4b6de9c366bb 00)

* Please review the disclaimer below.